Elicio Therapeutics (ELTX) Equity Income (2020 - 2022)
Elicio Therapeutics' (ELTX) quarterly Equity Income came in at $9000.0 in Q3 2022, down 55.0% YoY from $20000.0 in Q3 2021, and down 93.23% on a QoQ basis from $133000.0 in Q2 2022.
Elicio Therapeutics (ELTX) Equity Income (2020 - 2022) Analysis & Trends
Elicio Therapeutics (ELTX) has 3 years of Equity Income data on file, last reported at $9000.0 in Q3 2022.
- Quarterly Equity Income fell 55.0% year-over-year to $9000.0 in Q3 2022, while the trailing twelve-month figure through Mar 2023 was $142000.0 (up 197.93% YoY) and the FY2022 annual result came in at $151000.0, up 252.53% from the prior year.
- Equity Income slipped to $9000.0 in Q3 2022, from $133000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of $133000.0 in Q2 2022 to a low of -$139000.0 in Q4 2021.
- A 3-year average of -$1900.0 and a median of $14500.0 in 2021 frame the typical range for Equity Income.
- Annual changes were most pronounced in 2021 — Equity Income plunged 225.0% — and 2022, when it jumped 480.0%.
- Tracing ELTX's Equity Income over 3 years: stood at -$127000.0 in 2020, then declined by 9.45% to -$139000.0 in 2021, then surged by 106.47% to $9000.0 in 2022.
- The last three Equity Income figures came in at $9000.0 (Q3 2022), $133000.0 (Q2 2022), and $9000.0 (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.08 Mn |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 133,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | -139,000.00 |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | -35,000.00 |
| Mar 31, 2021 | 55,000.00 |
| Dec 31, 2020 | -127,000.00 |
| Jun 30, 2020 | 28,000.00 |
| Mar 31, 2020 | 28,000.00 |